Tolerance Bio will increase health span by preserving, restoring, and MODULATING the function of the thymus, the master regulator of immune tolerance

Gradient background with abstract geometric design

News & UPDATES

Featured
Tolerance Bio Licenses Clinical-Stage Anti-IL-33 Monoclonal Antibody from Tanabe Pharma to Expand Thymus-Focused Clinical Pipeline
Read more →
Tolerance Bio Licenses Clinical-Stage Long-Acting Interleukin-7 Therapy Efineptakin Alfa from NeoImmuneTech to Advance Programs Targeting Thymic Function and Immune Resilience
Read more →
Tolerance Bio’s Implanted iPSC-derived Thymic Organoids Enable In Vivo Positive Selection of Human T cells and Tumor Burden Reduction in Melanoma 
Read more →

FOLLOW US ON LINKEDIN